Lung Transplant

HomePatientsLung Disease Week at the ATS2014 ▶ Lung Transplant
Lung Transplant Week

Lung Transplant Week

Welcome Message

It is with great pleasure that we welcome you to “Lung Transplant Week at the ATS,” a joint effort of the American Thoracic Society and the Lung Transplant Foundation (LTF).

Lung Transplant Week is an especially important opportunity for us to bring attention the state of lung transplant. Lung transplantation is not a disease but rather a process and often the only available opportunity for patients with end stage lung disease. In 2013 there were approximately 12,000 pairs of lungs donated for transplantation and alarmingly roughly only 15% were acceptable for transplantation. Over the same time period, there were 1794 lung transplant recipients with 60% of transplants in men and 40% in women. There are currently approximately 1650 individuals waiting for lung transplants.

As you might imagine lungs are among the most difficult solid organ to transplant. An individual inhales 3.2 pints of oxygen in every eight seconds of breathing. And in that breath, there are hundreds of millions of germs and bacteria. There are no medicines specifically designed for lung transplant. As such, long term outcomes are poor when compared to other solid organ transplant statistics with 45% to 50% of those transplanted not surviving the most crucial first year of transplantation. Of those that do survive, 50% don’t live past five years and of those remaining, only 20% live longer than 10 years.

There are many encouraging areas of research that show promise in making more lungs available and viable for donation as well as methods for diagnosing and anticipating the various forms of rejection associated with the lung transplant process. The ATS and the LTF support those who are working diligently to develop these treatments and the future medicines that will improve the lives of lung transplant recipients.

Jeff Goldstein

Jeff Goldstein
President, Lung Transplant Foundation
Member, ATS Public Advisory Roundtable



In June 2009, the national Lung Transplant Foundation (LTF) was founded as a non-profit organization by a group of lung transplant recipients from Durham and Chapel Hill, NC. These recipients from Duke University and UNC Hospitals realized promotion and funding of research to improve the post lung transplant experience and long term outcomes was severely lacking, so they created the LTF to tackle one of the most difficult and life-threatening issues facing transplant recipients, chronic rejection or bronchiolitis obliterans syndrome (BOS).